ArticleCell research2020

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.

Shuai Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.